Zhongzhi Pharmaceutical Holdings Limited (3737.HK)
HKD 0.91
(0.0%)
HKD 0.91
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 101.5 Million | 284.57 Million | 178.37 Million | 93.17 Million | 167.82 Million | 79.82 Million |
| Net Income | 207.58 Million | 106.38 Million | 52.12 Million | 138.53 Million | 114.69 Million | 85.06 Million |
| Depreciation & Amortization | 102.07 Million | 93.58 Million | 82.46 Million | 99.74 Million | 61.87 Million | 24.24 Million |
| Deferred income taxes | - | - | - | 100.07 Million | 105.84 Million | - |
| Stock-based compensation | - | - | - | 1.11 Million | 1.63 Million | - |
| Change in working capital | -144.4 Million | -73.38 Million | -10.99 Million | -101.19 Million | -107.48 Million | -87.5 Million |
| Other non-cash items | -63.74 Million | 157.98 Million | 54.78 Million | -145.1 Million | -8.73 Million | 58.01 Million |
| Investing Cash Flow | -202.75 Million | 13.38 Million | -135.98 Million | -250.42 Million | -56.61 Million | 8.7 Million |
| Investments in PPE | -171.42 Million | -88.4 Million | -185.84 Million | -113.98 Million | -57.16 Million | -75.19 Million |
| Acquisitions | 141 Thousand | -4.28 Million | -22.69 Million | -143 Million | -560 Thousand | -13.12 Million |
| Investment purchases | -82.78 Million | -5.99 Million | -51.71 Million | -463.38 Million | -203.13 Million | -254 Million |
| Sales/Maturities of investments | 27.19 Million | 81.22 Million | 74.41 Million | 320 Million | 213.22 Million | 267.12 Million |
| Other Investing Activities | 24.11 Million | 30.84 Million | 49.86 Million | 149.95 Million | -8.97 Million | 83.89 Million |
| Financing Cash Flow | -154.61 Million | -68.14 Million | -40.83 Million | -71.93 Million | -64.85 Million | -58.75 Million |
| Debt repayment | -13.58 Million | -46.95 Million | -45.41 Million | -38.26 Million | -34.01 Million | -12.23 Million |
| Dividends payments | -116.14 Million | -230 Thousand | - | -70.41 Million | -60.82 Million | -58.75 Million |
| Common Stock Repurchased | - | - | -4.38 Million | -12.32 Million | - | - |
| Common Stock Issuance | - | - | 25.65 Million | -12.32 Million | - | - |
| Other Financing Activities | 485 Thousand | -20.96 Million | 7.45 Million | 39.94 Million | 7.25 Million | -12.36 Million |
| Accounts receivables | -18.21 Million | -13.59 Million | 10.03 Million | -52.99 Million | -86.98 Million | -41.58 Million |
| Accounts payables | 9.85 Million | -82.02 Million | -18.3 Million | 44.73 Million | -59.61 Million | - |
| Inventory | -10.65 Million | -59.79 Million | -21.02 Million | -48.19 Million | -20.49 Million | -45.91 Million |
| Other working capital | -125.39 Million | 82.02 Million | 18.3 Million | -44.73 Million | 59.61 Million | 46.4 Million |
| Cash at beginning of period | 381.01 Million | 153.38 Million | 151.03 Million | 380.33 Million | 332.69 Million | 300.12 Million |
| Cash at end of period | 124.36 Million | 381.01 Million | 153.38 Million | 151.03 Million | 380.33 Million | 332.69 Million |
| Capital Expenditure | -171.42 Million | -88.4 Million | -185.84 Million | -113.98 Million | -57.16 Million | -75.19 Million |
| Effect of forex changes on cash | -769 Thousand | -2.18 Million | 781 Thousand | -125 Thousand | 1.28 Million | 2.79 Million |
| Net cash flow / Change in cash | -256.64 Million | 227.62 Million | 2.34 Million | -229.3 Million | 47.63 Million | 32.57 Million |
| Free Cash Flow | -69.92 Million | 196.16 Million | -7.47 Million | -20.81 Million | 110.65 Million | 4.63 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 83.44 Million | 27.87 Million | 207.58 Million | 134.9 Million | 106.38 Million | 29.33 Million |
| Depreciation & Amortization | 51.05 Million | 52.06 Million | 102.07 Million | 50.01 Million | 93.58 Million | 47.65 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -104.41 Million | -28.72 Million | -144.4 Million | -125.54 Million | -73.38 Million | 39.94 Million |
| Other non-cash items | 77.33 Million | 10.08 Million | -63.74 Million | -19.17 Million | 157.98 Million | 77.26 Million |
| Investing Cash Flow | -81 Million | -117.09 Million | -202.75 Million | -85.66 Million | 13.38 Million | 50.14 Million |
| Investments in PPE | -96.68 Million | -92.7 Million | -171.42 Million | -76.47 Million | -88.4 Million | -50.02 Million |
| Acquisitions | - | - | 141 Thousand | - | -4.28 Million | - |
| Investment purchases | - | - | -82.78 Million | - | -5.99 Million | - |
| Sales/Maturities of investments | - | - | 27.19 Million | - | 81.22 Million | - |
| Other Investing Activities | 15.68 Million | -24.39 Million | 24.11 Million | -9.18 Million | 30.84 Million | 100.17 Million |
| Financing Cash Flow | -27.73 Million | -59.6 Million | -154.61 Million | -95.01 Million | -68.14 Million | -35.62 Million |
| Debt repayment | -1.99 Million | - | -13.58 Million | -24.13 Million | -46.95 Million | - |
| Dividends payments | -23.13 Million | -46.64 Million | -116.14 Million | -69.5 Million | -230 Thousand | - |
| Common Stock Repurchased | -1.87 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -732 Thousand | -12.95 Million | 485 Thousand | -1.38 Million | -20.96 Million | -35.62 Million |
| Accounts receivables | -106.57 Million | -823 Thousand | -18.21 Million | -17.39 Million | -13.59 Million | 53.79 Million |
| Accounts payables | - | - | 9.85 Million | - | -82.02 Million | - |
| Inventory | -19.31 Million | -28.41 Million | -10.65 Million | 17.75 Million | -59.79 Million | -70.71 Million |
| Other working capital | 21.47 Million | 512 Thousand | -125.39 Million | -125.9 Million | 82.02 Million | 56.87 Million |
| Cash at beginning of period | 124.36 Million | 241.79 Million | 381.01 Million | 381.01 Million | 153.38 Million | 173.53 Million |
| Cash at end of period | 122.9 Million | 124.36 Million | 124.36 Million | 241.79 Million | 381.01 Million | 381.01 Million |
| Capital Expenditure | -96.68 Million | -92.7 Million | -171.42 Million | -76.47 Million | -88.4 Million | -50.02 Million |
| Effect of forex changes on cash | -132 Thousand | -2.03 Million | -769 Thousand | 1.26 Million | -2.18 Million | -1.24 Million |
| Net cash flow / Change in cash | -1.46 Million | -117.42 Million | -256.64 Million | -139.21 Million | 227.62 Million | 207.47 Million |
| Free Cash Flow | 10.72 Million | -31.39 Million | -69.92 Million | -36.27 Million | 196.16 Million | 144.17 Million |
TEP
PSMMY
300497
6151
GRAND
AVON